SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
President Donald Trump listens as Dr. Moncef Slaoui, the former head of GlaxoSmithKlines vaccines division, speaks about coronavirus vaccine development in the Rose Garden of the White House on May 15, 2020. (Photo: Drew Angerer/Getty Images)
Rep. Katie Porter is demanding a "full, independent" inspector general investigation into whether President Donald Trump flouted longstanding ethics laws to put a former pharmaceutical executive with a slew of potential conflicts of interest in charge of the White House initiative tasked with developing a Covid-19 vaccine.
"By evading these longstanding laws, the administration is harming public trust in the vaccine effort."
--Rep. Katie Porter
In a letter Wednesday to the inspectors general of the Health and Human Services Department and the Office of Personnel Management, the California Democrat expressed alarm at "reports that President Trump is violating ethics laws and established procedures in order to place individuals at the helm of his administration's vaccine research and development efforts without subjecting them to standard requirements of government employees."
"Abiding by clear and longstanding ethics guidelines prevents distrust and confusion," Porter wrote. "By evading these longstanding laws, the administration is harming public trust in the vaccine effort. As such, I request that you conduct an investigation into Dr. Moncef Slaoui's employment as the co-leader of Operation Warp Speed, make recommendations on his government employment status, and provide a public record on the results."
\u201cThe Administration put Big Pharma executives at the helm of efforts to develop a COVID vaccine. But they\u2019re not required to let the public know if they\u2019d financially benefit from the vaccine that makes it into mass production. This deserves a full, independent investigation.\u201d— Rep. Katie Porter (@Rep. Katie Porter) 1597864088
Trump appointed Slaoui to help lead the $10 billion public-private coronavirus vaccine effort in May, prompting outcry from government watchdogs who said Slaoui's current investments in the pharmaceutical industry and past as an executive at healthcare giant GlaxoSmithKline should have disqualified him from serving in the role.
Last month, as Common Dreams reported, the HHS inspector general ruled that Slaoui does not have to disclose or sell off his investments in the pharmaceutical industry because the Trump administration classified him as a "volunteer contractor" rather than a federal employee.
"Dr. Slaoui has 'maintained that as a consultant, he is only offering advice and not making decisions,' but considering his leading role as one of two individuals in charge of Operation Warp Speed, this seems implausible," Porter wrote Wednesday. "Though Dr. Slaoui had said he would accept a payment of only $1 for his services, Politico reported [late last month] that the arrangement is covered through a $611,500 contract."
The California Democrat noted that former Pfizer executives William Erhardt and Rachel Harrigan are also covered by the contract, raising further concerns that Trump appointees are unethically profiteering off a taxpayer-funded initiative.
"This process must be transparent in order to instill confidence in the American people that this vaccine is safe and effective," Porter wrote. "Any sense that the leaders of Operation Warp Speed are working to serve their respective interests, rather than the public health and safety of the American people, threatens to undermine this objective."
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Rep. Katie Porter is demanding a "full, independent" inspector general investigation into whether President Donald Trump flouted longstanding ethics laws to put a former pharmaceutical executive with a slew of potential conflicts of interest in charge of the White House initiative tasked with developing a Covid-19 vaccine.
"By evading these longstanding laws, the administration is harming public trust in the vaccine effort."
--Rep. Katie Porter
In a letter Wednesday to the inspectors general of the Health and Human Services Department and the Office of Personnel Management, the California Democrat expressed alarm at "reports that President Trump is violating ethics laws and established procedures in order to place individuals at the helm of his administration's vaccine research and development efforts without subjecting them to standard requirements of government employees."
"Abiding by clear and longstanding ethics guidelines prevents distrust and confusion," Porter wrote. "By evading these longstanding laws, the administration is harming public trust in the vaccine effort. As such, I request that you conduct an investigation into Dr. Moncef Slaoui's employment as the co-leader of Operation Warp Speed, make recommendations on his government employment status, and provide a public record on the results."
\u201cThe Administration put Big Pharma executives at the helm of efforts to develop a COVID vaccine. But they\u2019re not required to let the public know if they\u2019d financially benefit from the vaccine that makes it into mass production. This deserves a full, independent investigation.\u201d— Rep. Katie Porter (@Rep. Katie Porter) 1597864088
Trump appointed Slaoui to help lead the $10 billion public-private coronavirus vaccine effort in May, prompting outcry from government watchdogs who said Slaoui's current investments in the pharmaceutical industry and past as an executive at healthcare giant GlaxoSmithKline should have disqualified him from serving in the role.
Last month, as Common Dreams reported, the HHS inspector general ruled that Slaoui does not have to disclose or sell off his investments in the pharmaceutical industry because the Trump administration classified him as a "volunteer contractor" rather than a federal employee.
"Dr. Slaoui has 'maintained that as a consultant, he is only offering advice and not making decisions,' but considering his leading role as one of two individuals in charge of Operation Warp Speed, this seems implausible," Porter wrote Wednesday. "Though Dr. Slaoui had said he would accept a payment of only $1 for his services, Politico reported [late last month] that the arrangement is covered through a $611,500 contract."
The California Democrat noted that former Pfizer executives William Erhardt and Rachel Harrigan are also covered by the contract, raising further concerns that Trump appointees are unethically profiteering off a taxpayer-funded initiative.
"This process must be transparent in order to instill confidence in the American people that this vaccine is safe and effective," Porter wrote. "Any sense that the leaders of Operation Warp Speed are working to serve their respective interests, rather than the public health and safety of the American people, threatens to undermine this objective."
Rep. Katie Porter is demanding a "full, independent" inspector general investigation into whether President Donald Trump flouted longstanding ethics laws to put a former pharmaceutical executive with a slew of potential conflicts of interest in charge of the White House initiative tasked with developing a Covid-19 vaccine.
"By evading these longstanding laws, the administration is harming public trust in the vaccine effort."
--Rep. Katie Porter
In a letter Wednesday to the inspectors general of the Health and Human Services Department and the Office of Personnel Management, the California Democrat expressed alarm at "reports that President Trump is violating ethics laws and established procedures in order to place individuals at the helm of his administration's vaccine research and development efforts without subjecting them to standard requirements of government employees."
"Abiding by clear and longstanding ethics guidelines prevents distrust and confusion," Porter wrote. "By evading these longstanding laws, the administration is harming public trust in the vaccine effort. As such, I request that you conduct an investigation into Dr. Moncef Slaoui's employment as the co-leader of Operation Warp Speed, make recommendations on his government employment status, and provide a public record on the results."
\u201cThe Administration put Big Pharma executives at the helm of efforts to develop a COVID vaccine. But they\u2019re not required to let the public know if they\u2019d financially benefit from the vaccine that makes it into mass production. This deserves a full, independent investigation.\u201d— Rep. Katie Porter (@Rep. Katie Porter) 1597864088
Trump appointed Slaoui to help lead the $10 billion public-private coronavirus vaccine effort in May, prompting outcry from government watchdogs who said Slaoui's current investments in the pharmaceutical industry and past as an executive at healthcare giant GlaxoSmithKline should have disqualified him from serving in the role.
Last month, as Common Dreams reported, the HHS inspector general ruled that Slaoui does not have to disclose or sell off his investments in the pharmaceutical industry because the Trump administration classified him as a "volunteer contractor" rather than a federal employee.
"Dr. Slaoui has 'maintained that as a consultant, he is only offering advice and not making decisions,' but considering his leading role as one of two individuals in charge of Operation Warp Speed, this seems implausible," Porter wrote Wednesday. "Though Dr. Slaoui had said he would accept a payment of only $1 for his services, Politico reported [late last month] that the arrangement is covered through a $611,500 contract."
The California Democrat noted that former Pfizer executives William Erhardt and Rachel Harrigan are also covered by the contract, raising further concerns that Trump appointees are unethically profiteering off a taxpayer-funded initiative.
"This process must be transparent in order to instill confidence in the American people that this vaccine is safe and effective," Porter wrote. "Any sense that the leaders of Operation Warp Speed are working to serve their respective interests, rather than the public health and safety of the American people, threatens to undermine this objective."